Overview

Clopidogrel Resistance and Embolism in Carotid Artery Stenting

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of the ticlopidine + ginko biloba compared to clopidogrel in clopidogrel resistant patients undergoing carotid artery stent placement. The investigators hypothesized that ticlopidine + ginko biloba is superior than clopidogrel in terms of post-stent ischemic lesions in these patients without serious complications.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Collaborator:
Yuyu Pharma, Inc.
Treatments:
Clopidogrel
Ticlopidine